General Announcement::Notice of Redemption to the Holders of 4.400% Senior Notes due 2023

Issuer & Securities

Issuer/ Manager
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Securities
TAKEDAPHARUS$1.5B4.4%231126A - US874060AR79 - 8E1B
TAKEDAPHARUS$1.5B4.4%231126R - USJ8129EAX60 - LJLB
TAKEDA US$1.495564B4.4%N231126 - US874060AT36 - EYEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
28-Sep-2022 08:01:00
Status
New
Announcement Sub Title
Notice of Redemption to the Holders of 4.400% Senior Notes due 2023
Announcement Reference
SG220928OTHRQLNS
Submitted By (Co./ Ind. Name)
Izumi Masuyama
Designation
Lead of SEC Reporting
Description (Please provide a detailed description of the event in the box below)
Notice is hereby given that Takeda Pharmaceutical Company Limited, a joint-stock corporation (kabushiki kaisha) organized under the laws of Japan (the Company), will redeem $1,000,000,000 of the total $1,500,000,000 outstanding aggregate principal amount of the Notes on October 27, 2022.

Attachments

Takeda Redemption Notice to Holders of Senior Notes due 2023.pdf
Total size =109K